Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2397155
Title:
Procédés et compositions pour le traitement d'infections persistantes en inhibant la voie de la mort cellulaire programmée (PD-1)
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
111626677
WO application number:
Type:
European patent granted for BE
Status:
Revoked
Publication number:
2397155
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
08/06/2006
Grant date:
13/12/2017
EP publication date:
21/12/2011
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
13/12/2017
EP B1 publication date:
13/12/2017
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/06/2018
Expiration date (if granted and all annual fees paid):
08/06/2026
Revocation Date:
18/10/2023
Applicant
1
Name:
Dana-Farber Cancer Institute, Inc.
Legal Form:
From:
13/12/2017
Address:
450 Brookline Avenue, Boston, MA 02215, United States (US)
To:
2
Name:
The Brigham and Women's Hospital, Inc.
Legal Form:
From:
13/12/2017
Address:
75 Francis Street, Boston MA 02115, United States (US)
To:
3
Name:
Emory University
Legal Form:
From:
13/12/2017
Address:
1599 Clifton Road NE
4th Floor, Atlanta, GA 30322, United States (US)
To:
4
Name:
President and Fellows of Harvard College
Legal Form:
From:
13/12/2017
Address:
17 Quincy Street, Cambridge, MA 02138, United States (US)